BCL2 and Cognitive impairment: Consistent with our results, Shaker et al. [44] showed the BBR-mediated inhibition of apoptosis via upregulating the Bcl-2 protein level and downregulating the Bax expression and Bax/Bcl-2 ratio in doxorubicin-induced cognitive impairment in rats.